In vitro and in vivo protective effect of atriopeptin III on ischemic acute renal failure.
about
Acute renal failure: definitions, diagnosis, pathogenesis, and therapyScience review: natriuretic peptides in critical illnessThe physiological and clinical importance of sodium potassium ATPase in cardiovascular diseasesThe Trade-Off between Dietary Salt and Cardiovascular Disease; A Role for Na/K-ATPase Signaling?Changes in intrarenal oxygenation as evaluated by BOLD MRI in a rat kidney model for radiocontrast nephropathyAcute renal failure. Lessons from pathophysiologyEvaluation of changes in intrarenal oxygenation in rats using multiple gradient-recalled echo (mGRE) sequence.Novel approaches to the treatment of acute renal failure.Endogenous cardiotonic steroids: physiology, pharmacology, and novel therapeutic targets.Natriuretic peptides and acute renal failure.Mechanisms and amelioration of acute renal allograft failure in the cyclosporine era.Natriuretic peptides in acute and chronic kidney disease and during renal replacement therapy.Pharmacological strategies to prevent contrast-induced acute kidney injury.Atrial natriuretic factor: a protective role after acute renal ischemia? Is there room for it in kidney transplantation?Contributions of nuclear magnetic resonance to study of acute renal failure.Diuretics in acute renal failure.Atrial natriuretic peptides in the treatment of acute renal failure.The role of calcium in the pathogenesis of acute renal failure.Role of L-arginine-derived NO in ischemic acute renal failure in the rat.The therapeutic potential of synthetic human atrial natriuretic peptide in nephrotic syndrome: a randomized controlled trialDifferential effects of human atrial natriuretic peptide and furosemide on glomerular filtration rate and renal oxygen consumption in humans.Long-term infusion of atrial natriuretic peptide (ANP) improves renal blood flow and glomerular filtration rate in clinical acute renal failure.
P2860
Q24563291-790BDFDB-BDDA-4C68-B4E3-50F583B6F7F9Q24799740-47216257-764F-40D4-BCAB-99656D1A3765Q26764938-7E223040-19DA-4BBA-BA59-158B3447C08EQ26865026-9341F037-E861-4319-8585-2B285515A28EQ28364010-9FE89448-A8FB-4827-80E1-6B67202E48CAQ33559985-90476ED8-736F-40B6-AD39-1E4CAC544731Q34038475-B8C7C223-BBE9-4DCD-8587-3A3FCF323FABQ34075164-8406E2C8-E986-459C-A095-A385BB3A2E8CQ34605877-88CA40F4-DDA1-4D4E-8A3F-F276ED5071F6Q35169820-DE0EA0D8-0728-4730-B57E-4C4AE343416EQ35349065-161CA598-50FD-4839-ABDE-26CA5C9282FEQ36317204-28ED64C9-B0AC-4763-872C-2ED27C6F067BQ37639849-879B9F7E-A76D-4E36-B112-1D2764B5C53FQ37855607-B1584D24-DDB0-41F6-B8FF-4E01DF4BF7E9Q38767118-25436C37-C080-4540-A21B-2778811A8740Q40752711-484867B6-FF25-4CAA-89E4-0FB2DAA4752BQ40766350-C94E77E7-23B7-49EB-9FCF-34641C98F42AQ41431125-0AE4F8E4-EC08-4DC3-858D-DDA64467C6BBQ41664552-3A9F87DB-9880-4FF7-9C2A-DE645461BB50Q41963583-77799AC1-CC13-434F-A098-EA737E1EC1F8Q45163732-6BF7BFAC-18AF-4287-BF34-71CEFC21524BQ51360063-44BFFC0B-FDFA-4E78-90DB-4388570A8D2D
P2860
In vitro and in vivo protective effect of atriopeptin III on ischemic acute renal failure.
description
1987 nî lūn-bûn
@nan
1987年の論文
@ja
1987年論文
@yue
1987年論文
@zh-hant
1987年論文
@zh-hk
1987年論文
@zh-mo
1987年論文
@zh-tw
1987年论文
@wuu
1987年论文
@zh
1987年论文
@zh-cn
name
In vitro and in vivo protectiv ...... ischemic acute renal failure.
@ast
In vitro and in vivo protectiv ...... ischemic acute renal failure.
@en
type
label
In vitro and in vivo protectiv ...... ischemic acute renal failure.
@ast
In vitro and in vivo protectiv ...... ischemic acute renal failure.
@en
prefLabel
In vitro and in vivo protectiv ...... ischemic acute renal failure.
@ast
In vitro and in vivo protectiv ...... ischemic acute renal failure.
@en
P2093
P2860
P356
P1476
In vitro and in vivo protectiv ...... ischemic acute renal failure.
@en
P2093
J I Shapiro
M Nakamoto
P F Shanley
R W Schrier
P2860
P304
P356
10.1172/JCI113124
P407
P577
1987-09-01T00:00:00Z